These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33086249)

  • 1. Tamoxifen prevention of meningioma and its proposal for the treatment of meningioma. Revisiting old data in the light of recent epidemiological observations.
    Altinoz MA
    Eur J Cancer Prev; 2021 Sep; 30(5):409-412. PubMed ID: 33086249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of tamoxifen with meningioma: a population-based study in Sweden.
    Ji J; Sundquist J; Sundquist K
    Eur J Cancer Prev; 2016 Jan; 25(1):29-33. PubMed ID: 25642792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study.
    Goodwin JW; Crowley J; Eyre HJ; Stafford B; Jaeckle KA; Townsend JJ
    J Neurooncol; 1993 Jan; 15(1):75-7. PubMed ID: 8455065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiestrogenic therapy of meningiomas--a pilot study.
    Markwalder TM; Seiler RW; Zava DT
    Surg Neurol; 1985 Sep; 24(3):245-9. PubMed ID: 4023903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mifepristone: antineoplastic studies.
    Sartor O; Figg WD
    Clin Obstet Gynecol; 1996 Jun; 39(2):498-505. PubMed ID: 8734014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer.
    Assender JW; Gee JM; Lewis I; Ellis IO; Robertson JF; Nicholson RI
    J Clin Pathol; 2007 Nov; 60(11):1216-21. PubMed ID: 17965220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer.
    Jordan VC
    Breast Cancer Res Treat; 1995; 36(3):267-85. PubMed ID: 8573710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
    Altinoz MA; Ozpinar A; Elmaci I
    Neurosurg Rev; 2019 Jun; 42(2):351-369. PubMed ID: 29453736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer.
    Howell SJ; Johnston SR; Howell A
    Best Pract Res Clin Endocrinol Metab; 2004 Mar; 18(1):47-66. PubMed ID: 14687597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility treatment is associated with multiple meningiomas and younger age at diagnosis.
    Shahin MN; Magill ST; Dalle Ore CL; Viner JA; Peters PN; Solomon DA; McDermott MW
    J Neurooncol; 2019 May; 143(1):137-144. PubMed ID: 30868355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
    Cuzick J; Forbes JF; Sestak I; Cawthorn S; Hamed H; Holli K; Howell A;
    J Natl Cancer Inst; 2007 Feb; 99(4):272-82. PubMed ID: 17312304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.
    Powles TJ; Ashley S; Tidy A; Smith IE; Dowsett M
    J Natl Cancer Inst; 2007 Feb; 99(4):283-90. PubMed ID: 17312305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
    Hillner BE
    Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen- and progesterone-receptors in meningiomas. Review article.
    Goffin J
    Clin Neurol Neurosurg; 1986; 88(3):169-75. PubMed ID: 3536253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective estrogen receptor modulation: the search for an ideal hormonal therapy for breast cancer.
    Dhingra K
    Cancer Invest; 2001; 19(6):649-59. PubMed ID: 11486708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen/norfloxacin interaction leading to QT interval prolongation in a female patient with extracranial meningioma.
    Slovacek L; Priester P; Petera J; Slanska I; Kopecky J
    Bratisl Lek Listy; 2011; 112(6):353-4. PubMed ID: 21692412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal manipulation of meningiomas in vitro.
    Olson JJ; Beck DW; Schlechte J; Loh PM
    J Neurosurg; 1986 Jul; 65(1):99-107. PubMed ID: 3712034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
    ; Davies C; Godwin J; Gray R; Clarke M; Cutter D; Darby S; McGale P; Pan HC; Taylor C; Wang YC; Dowsett M; Ingle J; Peto R
    Lancet; 2011 Aug; 378(9793):771-84. PubMed ID: 21802721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.